Covestor LTD Seagen Inc. Transaction History

Covestor LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $14,363 - $16,212	75 Added 20.05%	449 $95,000
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $11,258 - $12,375	-60 Reduced 13.82%	374 $72,000
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $53,332 - $84,887	-418 Reduced 49.06%	434 $88,000
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $4,694 - $5,566	-40 Reduced 4.48%	852 $109,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $101,181 - $134,722	748 Added 519.44%	892 $122,000
Q2 2022 Aug 10, 2022	SELL	$108.81 - $179.33 $326 - $537	-3 Reduced 2.04%	144 $26,000
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $20,692 - $27,308	-173 Reduced 54.06%	147 $21,000
Q4 2021 Feb 10, 2022	BUY	$142.57 - $190.86 $45,622 - $61,075	320 New	320 $50,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.